The worldwide feed acidifiers market is estimated to grow at a CAGR of 4.5% between 2018 and 2026. Feed acidifiers act as the mold inhibitors and enhance the growth of farm animals thereby increasing its productivity. This is the major factor expected to drive demand for these products which is also supported by the fact of banning the use of antibiotics in animal feed.
These products are added to feed to lower the pH level microbial cytoplasm, gut, which inhibits rapid growth of several types of pathogenic intestinal micro flora. This inhibition reduces the amount of micro flora that compete for host nutrients and in turn results in enhanced growth and hence performance of the farm animal. These components in feed are specified microorganism that positively affects the nutrition by improving the balance of pathogenic to beneficial bacteria in the gut. These are digestible components in feed competing with pathogens that regulate gut cell adhesion. Direct acting gut flora modulators such as essential are compounds directly modulating the microflora via growth inhibition. The products with specific functionality are essential components animal feed. Increasing focus on feed for higher productivity of farm animals has driven feed acidifiers demand.
Various research projects have been undertaken by numerous animal nutritional organizations such as the European Federation of Animal Sciences on these products that effects on performance of animals. The antimicrobial properties of the active ingredients of feed acidifiers are significant. Two different commercial blends of organic and inorganic acidifier compounds could alleviate the growth depression induced by a challenge with Clostridium perfringens in chickens. Acidifiers such as the biotronic helps in enhancing antimicrobial activity of organic acids and phytochemicals against Gram-negative bacteria, enhancing the growth performance, hence maximizing profit from the farm animals. These are some of the recent developments in the industry and with increasing demand for these products the market is expected to expand more rapidly in the near future.
Some of the functional advantages that these products are that these offer rather than only being a substitute but also include the economical adhesion for microorganisms to the epithelial receptors possibly will prevent attachment of the pathogenic bacteria, higher rate of synthesis of lactic acid and reduction of intestinal pH, aggregation of these pathogenic bacteria and production of a specific antibacterial substance, reduction in production of toxic amines and decrease in ammonia level in gastro-intestinal tract, help in beneficial reactions in the immune system of the intestine, which is an improved intestinal defense against viral infections.
Asia Pacific is expected to witness the fastest market growth owing to increasing number of feed processors in the region. The mounting surge in meat processors and shift in consumer demand for organic food products have be identified as some of the major factors responsible for driving the regional market. It is a significantly growing market. Several new product launches, under penetrated and unpenetrated market dynamics, numerous expansion activities within the ingredient manufacturers, rising purchasing power, surging demand for healthy and nutrient rich feed are the most important factors driving the Asia Pacific market. Europe is projected to be the largest market by 2026. Spain was the first country to put a ban on antibiotics. Several countries in the European Union completely banned the use of remaining antibiotics in feed processing including flavophospholipol, salinomycin-Na, avilamycin and monensin-Na. This created an immense demand for feed acidifiers especially for the farm animals.
Some of the primary market participants include Pancosma SA, Nutrex NV, Biomin Holding GmbH, Impextraco NV , Novus International, Inc. , Perstorp Holding AB, Kemin Industries, Inc., Kemira OYJ , Yara International ASA, Kemin Industries, BASF SE, Koninklijke DSM N.V., Cargil, Kemin Industries, Novozymes, Inc., Novus International, Inc., Addcon, Lallemand, Inc., Beneo Group and Chr. Hansen Holding A/S.